SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-22-006123
Filing Date
2022-02-09
Accepted
2022-02-09 15:06:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ea155204-s3a1_inmedpharma.htm S-3/A 64919
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP REGARDING LEGALITY OF SECURITIES BEI ea155204ex5-1_inmedpharma.htm EX-5.1 22884
3 GRAPHIC ex5-1_001.jpg GRAPHIC 3885
4 GRAPHIC ex5-1_002.jpg GRAPHIC 3206
  Complete submission text file 0001213900-22-006123.txt   98824
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-3/A | Act: 33 | File No.: 333-262532 | Film No.: 22606060
SIC: 2834 Pharmaceutical Preparations